Exane Asset Management bought a new stake in shares of CIGNA Co. (NYSE:CI) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 982 shares of the health services provider’s stock, valued at approximately $167,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. FMR LLC grew its holdings in shares of CIGNA by 10.8% during the second quarter. FMR LLC now owns 7,561,105 shares of the health services provider’s stock valued at $1,285,010,000 after buying an additional 734,965 shares during the last quarter. Massachusetts Financial Services Co. MA grew its holdings in shares of CIGNA by 3.0% during the second quarter. Massachusetts Financial Services Co. MA now owns 5,611,743 shares of the health services provider’s stock valued at $953,716,000 after buying an additional 164,623 shares during the last quarter. Veritas Asset Management LLP grew its holdings in shares of CIGNA by 81.1% during the second quarter. Veritas Asset Management LLP now owns 4,422,200 shares of the health services provider’s stock valued at $751,553,000 after buying an additional 1,979,877 shares during the last quarter. Sanders Capital LLC grew its holdings in shares of CIGNA by 9.1% during the second quarter. Sanders Capital LLC now owns 3,338,253 shares of the health services provider’s stock valued at $620,822,000 after buying an additional 277,860 shares during the last quarter. Finally, Boston Partners grew its holdings in shares of CIGNA by 0.6% during the second quarter. Boston Partners now owns 2,904,221 shares of the health services provider’s stock valued at $493,572,000 after buying an additional 17,675 shares during the last quarter. 89.42% of the stock is owned by institutional investors and hedge funds.

Several equities research analysts recently issued reports on the stock. Zacks Investment Research cut shares of CIGNA from a “strong-buy” rating to a “hold” rating in a report on Tuesday. SunTrust Banks raised their target price on shares of CIGNA and gave the stock a “buy” rating in a report on Thursday, September 27th. Cantor Fitzgerald assumed coverage on shares of CIGNA in a report on Wednesday, September 26th. They issued an “overweight” rating and a $245.00 target price on the stock. Leerink Swann raised their target price on shares of CIGNA from $235.00 to $250.00 and gave the stock an “outperform” rating in a report on Friday, September 21st. Finally, Credit Suisse Group raised their target price on shares of CIGNA from $223.00 to $237.00 and gave the stock an “outperform” rating in a report on Tuesday, September 18th. Four research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $229.73.

In other CIGNA news, Director William D. Zollars sold 238 shares of the stock in a transaction that occurred on Friday, September 14th. The shares were sold at an average price of $193.70, for a total value of $46,100.60. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO Eric P. Palmer purchased 2,828 shares of the firm’s stock in a transaction on Tuesday, July 31st. The stock was acquired at an average price of $177.61 per share, for a total transaction of $502,281.08. Following the completion of the transaction, the chief financial officer now directly owns 9,678 shares of the company’s stock, valued at approximately $1,718,909.58. The disclosure for this purchase can be found here. 1.10% of the stock is currently owned by company insiders.

CI traded up $1.09 during trading on Friday, hitting $207.09. The company’s stock had a trading volume of 2,600,475 shares, compared to its average volume of 2,350,325. The company has a current ratio of 0.38, a quick ratio of 0.38 and a debt-to-equity ratio of 0.35. CIGNA Co. has a one year low of $163.02 and a one year high of $227.13. The company has a market capitalization of $50.68 billion, a PE ratio of 19.80, a PEG ratio of 1.23 and a beta of 0.64.

CIGNA (NYSE:CI) last released its quarterly earnings results on Thursday, August 2nd. The health services provider reported $3.89 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.33 by $0.56. CIGNA had a net margin of 5.82% and a return on equity of 22.27%. The business had revenue of $11.50 billion for the quarter, compared to the consensus estimate of $11.20 billion. During the same period last year, the firm earned $2.91 earnings per share. The company’s quarterly revenue was up 10.9% on a year-over-year basis. Equities analysts forecast that CIGNA Co. will post 13.87 earnings per share for the current fiscal year.

About CIGNA

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.

Featured Article: Dividend Aristocrat Index

Institutional Ownership by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.